Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 770,664,256
  • Shares Outstanding, K 949,316
  • Annual Sales, $ 34,124 M
  • Annual Income, $ 5,240 M
  • EBIT $ 13,467 M
  • EBITDA $ 14,994 M
  • 60-Month Beta 0.43
  • Price/Sales 22.78
  • Price/Cash Flow 107.37
  • Price/Book 54.28

Options Overview Details

View History
  • Implied Volatility 31.89% ( +0.67%)
  • Historical Volatility 30.54%
  • IV Percentile 63%
  • IV Rank 28.92%
  • IV High 55.08% on 08/05/24
  • IV Low 22.46% on 06/28/24
  • Put/Call Vol Ratio 0.50
  • Today's Volume 29,420
  • Volume Avg (30-Day) 55,572
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 362,928
  • Open Int (30-Day) 307,594

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 5.48
  • Number of Estimates 8
  • High Estimate 5.59
  • Low Estimate 5.34
  • Prior Year 2.49
  • Growth Rate Est. (year over year) +120.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
767.61 +4.01%
on 11/06/24
930.51 -14.19%
on 10/17/24
-131.09 (-14.10%)
since 10/14/24
3-Month
767.61 +4.01%
on 11/06/24
972.53 -17.90%
on 08/22/24
-133.26 (-14.30%)
since 08/14/24
52-Week
561.65 +42.16%
on 12/15/23
972.53 -17.90%
on 08/22/24
+187.60 (+30.71%)
since 11/14/23

Most Recent Stories

More News
Why Are These 3 Vanguard ETFs Underperforming the S&P 500 Since Election Day?

Stocks in these "safe" sectors are selling off as investors gravitate toward growth.

MO : 55.43 (+0.33%)
VHT : 268.76 (-0.93%)
KO : 62.65 (-0.56%)
MRK : 98.75 (+0.25%)
JNJ : 152.31 (-0.61%)
UNH : 597.53 (-1.38%)
COMP : 6.67 (-0.45%)
COST : 926.80 (-0.74%)
VDC : 215.79 (+0.06%)
PG : 167.89 (+0.79%)
LLY : 797.73 (-1.73%)
VPU : 169.26 (-0.04%)
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

AstraZeneca just released some encouraging data about its weight loss drug candidates.

AZN : 65.61 (+0.49%)
LLY : 797.73 (-1.73%)
2 Top Growth Stocks to Buy on the Dip

Their recent issues are nothing to fret over for investors focused on the long game.

LLY : 797.73 (-1.73%)
REGN : 796.41 (-0.98%)
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years

These are income stocks you can buy and hold forever.

ABT : 115.46 (-0.24%)
KO : 62.65 (-0.56%)
LLY : 797.73 (-1.73%)
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?

Viking Therapeutics just revealed a new plan that could make waves in the weight loss industry.

VKTX : 54.49 (-1.04%)
LLY : 797.73 (-1.73%)
2 S&P 500 Dividend Stocks That Could Soar 30% or More, According to a Pair of Wall Street Analysts

If Wall Street's right, investors will get a lot more than just rising dividend payments from this pair.

MSFT : 427.41 (+0.52%)
BAC : 45.84 (-0.07%)
MS : 132.40 (-0.27%)
$SPX : 5,964.86 (-0.34%)
LLY : 797.73 (-1.73%)
Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with Disruptive Approaches to Treating Alzheimer’s Alzheimer’s...

ANVS : 6.97 (-5.94%)
LLY : 797.73 (-1.73%)
INMB : 5.58 (-2.45%)
XBI : 98.68 (-1.33%)
BIIB : 166.91 (+0.68%)
SAVA : 26.16 (+3.89%)
US Port Strike Threatens Supply of Popular Weight-Loss Drugs Ozempic, Wegovy, Mounjaro, and Zepbound

The ongoing US port strike on the East and Gulf coasts is causing significant disruptions to pharmaceutical supply chains, particularly for the popular weight-loss drugs Wegovy, Ozempic, Mounjaro, and...

NVO : 106.21 (-0.65%)
LLY : 797.73 (-1.73%)
3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance

Hims & Hers, Payoneer, and Astera Labs lead Q3 earnings with standout revenue growth, forecast upgrades, and strategic wins—stocks to watch for growth potential

FVRR : 28.93 (-2.00%)
PAYO : 10.26 (-0.58%)
ALAB : 89.02 (-0.31%)
HIMS : 22.61 (-18.08%)
NVO : 106.21 (-0.65%)
LLY : 797.73 (-1.73%)
UPWK : 15.24 (-3.05%)
Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?

Key TakeawaysLLY has declined 10.6% this month after disappointing third-quarter results.The drug maker has seen strong success in recent years, with several new drugs in the pipeline.Register now to see...

NVO : 106.21 (-0.65%)
LLY : 797.73 (-1.73%)
AMGN : 297.38 (-1.35%)
BIIB : 166.91 (+0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 841.33
2nd Resistance Point 835.22
1st Resistance Point 823.51
Last Price 797.73
1st Support Level 805.70
2nd Support Level 799.59
3rd Support Level 787.88

See More

52-Week High 972.53
Fibonacci 61.8% 815.57
Last Price 797.73
Fibonacci 50% 767.09
Fibonacci 38.2% 718.61
52-Week Low 561.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar